Please assess the completion status of the following clinical trial:

Trial Title: Does Montelukast Have an Affect on the Function of the Artery in Patients With Heart Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* male or female age 18-80 years, diagnosis of acute coronary syndrome with one increased Troponin assay,chest pain or chest pain syndrome, stable on initial medical therapy, painfree x 6 hours prior to enrollment~Exclusion Criteria:~* STEMI, Q-wave MI, \< 18years, women of childbearing potential, new LBBB, recurrent chest pain since hospitalization, IV nitroglycerine drip, hemodynamically unstable, history of asthma, history of liver disease or abnormal liver enzymes

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Montelukast sodium (Type: ACTIVE_COMPARATOR): Drug arm - Montelukast as a single dose 100 mg. To test the hypothesis of leukotriene inhibition.
- 2 (Type: PLACEBO_COMPARATOR): No drug given - no placebo available. To compare with active drug.

Based on this trial design, predict the completion outcome and termination type (if applicable).